We have observed
20 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after April 20, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
COMBINATORY CANCER TREATMENT
ANTIMICROBIAL NANOPARTICLE CONJUGATES
FILTER FOR A SMOKING ARTICLE
NANOPARTICLES AND USES THEREOF
A SMOKING ARTICLE AND A METHOD OF MANFACTURING A SMOKING ARTICLE
TREATMENT OF TOBACCO MATERIAL
MATERIAL FOR INCLUSION IN A SMOKING ARTICLE
SYNTHESIS AND ANTICANCER ACTIVITY OF ARYL AND HETEROARYL-QUINOLIN DERIVATIVES
CODING NUCLEOTIDE SEQUENCE OF MG53 PROTEIN WITH CODON OPTIMIZATION, RECOMBINANT AND USE THEREOF
REPROGRAMMING CANCER CELLS
HUMANIZED ANTI-MUC1* ANTIBODIES